THE NATIONAL INFLUENZA VACCINE

SUMMIT: UPDATERaymond A. Strikas, M.D.

Immunization Services DivisionNational Immunization Program

Coordinating Center for Infectious DiseasesCenters for Disease Control and Prevention

Department of Health and Human Services

NVAC Meeting – Washington, D.C.June 7, 2005

• Summit conceived in response to delays in influenza vaccine production and distribution in 2000

• Co-sponsored by AMA and CDC

• 1st two Summits:March and August 2001

• Annual meetings 2002-4

• Most recent meeting May 10-11, 2005

(Brief) History of the National Influenza Vaccine

Summit

The Summit is . . .•An annual meeting

•A concept

•An informal, action-oriented organization

•A resource

Composition of the Summit (1)

•Vaccine Manufacturers•Vaccine Distributors•Federal Agencies•Professional Medical

Organizations•Nursing Organizations•Public Health •Hospitals•Pharmacists

Composition of the Summit (2)

•Community Immunization Providers•Occupational Health Providers •Business•Private Health Insurance and

Managed Care•Long-term Care •Quality Improvement Organizations•Consumers•Advocacy Groups

Summit Working Groups (1)

•Community-based Vaccination Providers

•Occupational Vaccination Providers

•Payment Issues•Vaccine Distribution•Consumer Education

Summit Working Groups (2)

•Vaccine Reallocation•Physicians’ Issues•Communications•Long-term Care•Executive Committee

•Universal immunization (pending development)

2005 Summit Participation

•60 organizations

•154 individuals

THE 2005 NATIONAL INFLUENZA VACCINE

SUMMIT:

Themes and Recommendations

2005 Summit Themes•Lack of knowledge, indifference,

and/or frustration in the general public, priority persons, health care providers

•Stability of influenza vaccine supply

•Crisis planning (focus on vaccine supply and pandemic influenza)

Results of Theme Breakout Sessions – Theme I

• Avoid tiered or staggered vaccination recommendations

• If tiered recommendations necessary, open vaccination to all as soon as possible

• Vaccination recommendations should be clear, consistent, and clearly communicated to partners and the public

• Live attenuated vaccine recommendations should be clearly distinguished from those for inactivated vaccine

Results of Theme Breakout Sessions – Theme I (continued)

•Work towards policy changes encouraging/requiring health care worker (HCW) vaccination with professional groups, JCAHO, CMS

•Publish HCW vaccination rates by institution

Theme II Results/Recommendations

•Request vaccine pre-booking data from vaccine companies, distributors for state public health authorities

•Participate in federal government working group planning for 2005-06

Theme II – Results/Recommendations

(continued)•Form Universal Immunization working

group to consult with ACIP

•Objectives

– Ensure equity– Ensure proper health infrastructure

Theme II – Results/Recommendations

(continued)•Universal Immunization:

– Activities may include•Write a “White Paper” •Engage health insurers•Assess

– Vaccination impact– Cost effectiveness

•Expand vaccination season• Identify, employ additional strategies for

specific populations, e.g., children • Increase research: better vaccines,

technology for administration

Theme III Results/Recommendations

• Crisis: 30 million doses of vaccine available– Use antigen-sparing vaccination

– Close schools, day care settings

– Identify all long-term care settings (LTC), including assisted living, to facilitate vaccine delivery

– Close LTC to outside visitors

– Import vaccine if possible – use method other than IND

Theme III Results/Recommendations

(continued)• Crisis: Pandemic Influenza

– Consider Summit meeting on pandemic influenza, specifically vaccine purchase, distribution, administration:

– Discuss and promote an active government role in vaccine acquisition

– Promote open and direct private - public sector communication and collaboration to guarantee a rapid and equitable vaccine allocation and distribution

– Promote transparent allocation of vaccine based on need (priority)

– Promote the development of local capacity for vaccine allocation and distribution to priority groups

– Promote local leadership and active role in vaccine allocation and distribution

A Vision of theFuture of the National

Influenza Vaccine Summit• Remains a permanent but informal organization at the

national level

• Works year-round on the issues

• Flexible—can respond to contingencies

• Member survey to evaluate future directions for the Summit

• Could expand attention to broader array of adult vaccination issues